Event 
Partner 
Milestone 
2021-01-06
2021/1/17 Upcoming Advance Precision Cancer Medicine Forum
Advance Precision Cancer Medicine Forum (APCM)
Place:
Taipei
2020-06-05
ACT Genomics Is At A Fresh Turning Point Under COVID-19 In 2020 US BIO Digital
ACT Genomics is chosen by Taipei City Government as representative to join US BIO Digital, the world’s largest biotechnology exhibition, with OBI Pharma, belxbiopharma, NatureWise Biotech & Medicals, Far East Bio-tec and AcroMass Technology.
Place:
Taipei
2019-12-04
ACT Genomics will present precision medicine and cancer genomic profiling services at R224 in Taiwan Healthcare+ Expo
ACT Genomics will present precision medicine and cancer genomic profiling services at R224 in Taiwan Healthcare+ Expo from 12/05-12/08
Place:
Taipei
2019-07-24
Welcome to Visit Us at BioAsia-Taiwan at M228
ACTGenomics presents precision medicine and cancer genomic profiling services at M228 in BioAsia-Taiwan. Welcome to visit us.
Place:
Taipei
2018-12-04
Come meet us at the Precision Medicine World Conference in Silicon Valley!
Chief Scientific Officer Dr. Shu Jen Chen will be presenting on "Biomarker Solution for Immunotherapy: TMB and Beyond" at the 16th PMWC on Jan 22nd, focusing on TMB and Tumor Micro-environment.
Place:
Silicon Valley, CA
2018-11-01
Nov 28 Upcoming Asia Pacific Lung Cancer Forum
ACT Genomics and Taiwan Lung Cancer Society will hold Asia Pacific Lung Cancer Forum on November 28th at Taipei W hotel.
Place:
Taipei
2018-11-01
Nov 10-11 Last Call to Register for The Upcoming Annual 5th Hong Kong International Oncology Symposium (5th HKIOS)
ACT Genomics has the invaluable opportunity to be one of the sponsors of the 5th Hong Kong International Oncology Symposium (5th HKIOS) from 10th -11th November 2018 at Hong Kong Science and Technology Park (HKSTP) and City University of Hong Kong (CityU)
Place:
Hong Kong
2018-11-01
Nov 09 Friends of Cancer Research Will Present Initial Findings of TMB Hamonization in Washington, D.C.
MB Harmonization oral presentation titled “In silico assessment of variation in TMB quantification across diagnostic platforms: Phase 1 of the Friends of Cancer Research Harmonization Project “ is scheduled on November 9 th
Place:
USA
2018-11-01
Nov 07-11 ACT Genomics Shares Precision Medicine in Immunotherapy at SITC 2018
ACT Genomics introduced how innovative genomic profiling services can improve immunotherapy reponse rate with predictive biomarkers such as tumor mutational burden (TMB) in The 33rd Annual Meeting & Pre-Conference Programs (SITC 2018)
Place:
USA
2018-11-01
Nov 07 Educational Lecture at Kiang Wu Hospital, Macau on NGS Application to Guide Targeted & Immune Therapeutics by Lab Director of ACTG HK
Dr. Timothy T.C. Yip delivered a talk titled “The New Frontier in Precision Oncology Treatment: How Next-Generation Sequencing (NGS) testing can guide the use of targeted & immune drugs in treatment of cancer patients?”
Place:
Hong Kong
